Real-world data showed that low-risk patients who underwent transcatheter aortic valve replacement (TAVR) had 1-year ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Edwards Lifescienes also reported a big increase in pay for the structural heart device developer and manufacturer's median ...

The increased heart rate and strain upon the heart can be extremely dangerous for those who have some pre-existing heart ...

Peijia Medical Limited announced the successful completion of the first patient treatment using its ReachTactile™ robotic-assisted TAVR system. This system, which was used in a clinical trial at ...

The Harbor Long Term Growers ETF returned 5.97% underperforming the benchmark, the Russell 1000 Growth Index, which returned ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Truist lowered the firm’s price target on Medtronic (MDT) to $90 from $93 and keeps a Hold rating on the shares as part of a broad research ...

Arsenal could be forced to change their transfer plans after Mikel Arteta admitted there are "big question marks" over how some of their key players will recover from surgery. Antonee Robinson ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.